Biotech

All Articles

Daiichi pays for Merck $170M to develop bronchi cancer cells T-cell engager pact

.Merck &amp Co. has actually promptly redeemed some of the prices of its Harpoon Rehabs acquistion, ...

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin administered a spring tidy of its own pipeline in April, the provider has determined...

Eisai plants molecular adhesive SEED with $1.5 B biobucks handle

.Big Pharmas remain stuck to the idea of molecular glue degraders. The current provider to observe a...

Life scientific research credit score agency introduces along with $600M

.A brand new worldwide lifestyle science credit history company, dubbed Symbiotic Capital, has broug...

BMS ditches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another major bet coming from the Caforio age, terminating a deal...

Nuvation halts wager inhibitor after thinking about stage 1 information

.After looking at period 1 information, Nuvation Bio has decided to stop work with its single top BD...

' Professional intuitiveness' led FDA experts to back Zevra's uncommon health condition med

.Zevra Therapies' uncommon disease medicine appears to become on the pathway to approval this fall a...

Pfizer takes $230M hit after axing fell short DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene therapy failure has blown a $230 million op...

AC Immune observes 'landmark' possible in Alzheimer's drug records

.After more than twenty years of service neurodegenerative illness, Swiss biotech AC Invulnerable ca...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class potential

.GSK has actually ditched a period 2 individual papillomavirus (HPV) vaccine coming from its pipe af...